Role of Carbonic Anhydrases in the Progression of Renal Cell Carcinoma Subtypes: Proposal of a Unified Hypothesis
- 1 January 2006
- journal article
- review article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 24 (8) , 754-779
- https://doi.org/10.1080/07357900601062321
Abstract
Renal cell carcinoma (RCC) has the highest rate of occurrence within the US when compared with other countries. Recent advances in the basic research and molecular diagnostics of this malignancy have revealed that RCC is not a single disease, but it is a mixture of several types of malignancies with unique molecular mechanisms and pathological attributes. RCC is now divided into clear cell carcinoma (80% of all kidney cancers), papillary type 1 and papillary type 2 neoplasms (10–15% of all RCC patients) and RCC with chromophobic and oncocytic features, called the Birt-Hogg-Dube (BHD) subtype, in roughly 5% of all patients. Apart from these, neoplasms such as the tuberous sclerosis (TSC) syndrome may occur with a mixed pathological features with a renal presentation. In this review, molecular evidence, both direct and indirect, published so far on all these RCC subtypes have been analyzed to find out whether there is any common thread that could run through these disparate malignancies that happen to occur in a single organ, i.e., the kidney. We believe that the role played by the expression and certain non-traditional activities of the cabonic anhydrase (CA) family members, along with the differing levels of hypoxia induced within these tumors may be the most common denominators. Evidence is presented focusing on how the CA family members could participate in the genesis and progression of each and every one of these RCC subtypes and how their function could be influenced by hypoxia, activities of receptor type protein tyrosine kinases and certain other pre-disposing factors. These rationalizations point towards a unified hypothesis that may help explain the occurrence of all these RCC subtypes in a molecular manner. We hope that these analyses would a) stimulate further studies aimed toward a better understanding of the role played by carbonic anhydrases in RCC subtypes and b) would pave way to a better and rationally designed therapies to interfere with their function to benefit patients with RCC and possibly other cancers.Keywords
This publication has 101 references indexed in Scilit:
- The role of carbonic anhydrase IX overexpression in kidney cancerEuropean Journal Of Cancer, 2005
- mTOR, translational control and human diseaseSeminars in Cell & Developmental Biology, 2005
- Hypoxia activates the capacity of tumor‐associated carbonic anhydrase IX to acidify extracellular pHFEBS Letters, 2004
- The Tuberin-Hamartin Complex Negatively Regulates β-Catenin Signaling ActivityJournal of Biological Chemistry, 2003
- TSC1–TSC2: a complex tale of PKB-mediated S6K regulationNature Cell Biology, 2002
- A non‐hypoxic, ROS‐sensitive pathway mediates TNF‐α‐dependent regulation of HIF‐1αFEBS Letters, 2001
- Floating the Raft Hypothesis: Lipid Rafts Play a Role in Immune Cell ActivationImmunity, 2001
- Inactivation of the E-Cadherin-Mediated Cell Adhesion System in Human CancersThe American Journal of Pathology, 1998
- Portrait of a myristoyl switch proteinCurrent Opinion in Structural Biology, 1996
- The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells.The Journal of cell biology, 1993